18 Nov 2025
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 10/11/2025 tot 14/11/2025
|
30202010 Asset Managers and Custodians |
Other subject |
18 Nov 2025
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 10/11/2025 au 14/11/2025
|
30202010 Asset Managers and Custodians |
Other subject |
18 Nov 2025
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Buy back of own shares – week from 10/11/2025 to 14/11/2025
|
30202010 Asset Managers and Custodians |
Other subject |
18 Nov 2025
08:29 CET |
TITAN S.A. |
Programme de rachats d'actions
|
50101030 Cement |
Other subject |
18 Nov 2025
08:28 CET |
TITAN S.A. |
Share buyback programme
|
50101030 Cement |
Other subject |
18 Nov 2025
07:35 CET |
CRESCENT |
OCCASIONEEL PERSBERICHT - Crescent en Sol.One ondertekenen een driejarige raamovereenkomst
|
15101010 Telecommunications Equipment |
Other subject |
18 Nov 2025
07:34 CET |
CRESCENT |
OCCASIONAL PRESS RELEASE - Crescent and Sol.One sign a three-year frame agreement
|
15101010 Telecommunications Equipment |
Other subject |
18 Nov 2025
07:26 CET |
GBL |
GBL rondt met succes de verkoop af van 19,6m aandelen van Umicore
|
30202000 Diversified Financial Services |
Corporate life |
18 Nov 2025
07:25 CET |
GBL |
GBL annonce le succès de la cession de 19,6m d’actions Umicore
|
30202000 Diversified Financial Services |
Corporate life |
18 Nov 2025
07:25 CET |
GBL |
GBL successfully completes the sale of 19.6m shares of Umicore
|
30202000 Diversified Financial Services |
Corporate life |
17 Nov 2025
18:10 CET |
GBL |
GBL - Transacties op GBL-aandelen 17-11-2025
|
30202000 Diversified Financial Services |
Other financial transaction |
17 Nov 2025
18:09 CET |
GBL |
GBL - Transactions sur actions propres 17-11-2025
|
30202000 Diversified Financial Services |
Other financial transaction |
17 Nov 2025
18:08 CET |
GBL |
GBL - Transactions on GBL shares 17-11-2025
|
30202000 Diversified Financial Services |
Other financial transaction |
17 Nov 2025
18:00 CET |
HYBRID SOFTWARE GROUP PLC |
Notification of transactions in shares by persons discharging managerial responsibility ("PDMRs")
|
10101015 Software |
Other subject |
17 Nov 2025
18:00 CET |
HYBRID SOFTWARE GROUP PLC |
Update on the share repurchase program
|
10101015 Software |
Share history |
17 Nov 2025
17:50 CET |
VIOHALCO |
ElvalHalcor, filiale de Viohalco, soumet à la Bourse d'Athènes son rapport d'activités pour la période de 9 mois se terminant le 30 septembre 2025
|
55102015 Metal Fabricating |
Commercial results |
17 Nov 2025
17:50 CET |
VIOHALCO |
Viohalco subsidiary, ElvalHalcor, submits to the Athens Stock Exchange its trading update for the nine months ended 30 September 2025
|
55102015 Metal Fabricating |
Commercial results |
17 Nov 2025
17:45 CET |
MELEXIS |
Melexis: update over het aandeleninkoopprogramma
|
10102010 Semiconductors |
Corporate life |
17 Nov 2025
17:45 CET |
MELEXIS |
Melexis: update on the share buy-back program
|
10102010 Semiconductors |
Corporate life |
17 Nov 2025
17:45 CET |
SYENSQO |
Syensqo - Acquisition of own shares
|
55101000 Diversified Materials |
Change in Capital |
17 Nov 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
|
20101025 Health Services |
- |
17 Nov 2025
07:15 CET |
JENSEN-GROUP |
Inkoop eigen aandelen, wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
17 Nov 2025
07:15 CET |
JENSEN-GROUP |
Share buy-back, weekly update
|
50204000 Machinery: Industrial |
Other subject |
14 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
|
20103010 Biotechnology |
New |
14 Nov 2025
19:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)
|
20103010 Biotechnology |
New |
14 Nov 2025
18:39 CET |
FAGRON |
Fagron completes share buy-back program
|
20102010 Medical Equipment |
Other subject |
14 Nov 2025
18:39 CET |
FAGRON |
Voortgang aandeleninkoopprogramma Fagron
|
20102010 Medical Equipment |
Other subject |
14 Nov 2025
17:59 CET |
LOTUS BAKERIES |
Acquisition of treasury shares
|
45102020 Food Products |
Other subject |
14 Nov 2025
08:30 CET |
SYENSQO |
Syensqo exercises the first call option to redeem €500 million hybrid Bonds
|
55101000 Diversified Materials |
Change in Capital |
14 Nov 2025
08:15 CET |
BEKAERT |
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
|
55102010 Iron and Steel |
Legal |
14 Nov 2025
08:15 CET |
BEKAERT |
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst
|
55102010 Iron and Steel |
Legal |
14 Nov 2025
08:00 CET |
CMB.TECH |
PRESS RELEASE: CMB.TECH announces Q3 2025 results on 26/11/2025
|
50206030 Marine Transportation |
Other subject |
14 Nov 2025
08:00 CET |
NYXOAH SA |
Nyxoah Obtient des Engagements de Financement pouvant atteindre U.S. $77 Millions pour Supporter la Commercialisation de Genio aux États-Unis
|
20102010 Medical Equipment |
Other subject |
14 Nov 2025
08:00 CET |
KBC |
KBC Groep: informatie m.b.t. traditionele jaarlijkse kapitaalverhoging voor het personeel
|
30101010 Banks |
Other subject |
14 Nov 2025
08:00 CET |
KBC |
KBC Group: information regarding the traditional annual capital increase reserved for staff
|
30101010 Banks |
Other subject |
14 Nov 2025
08:00 CET |
CMB.TECH |
PRESS RELEASE: CMB.TECH announces Q3 2025 results on 26/11/2025
|
50206030 Marine Transportation |
Additional regulated information required to be disclosed under the laws of a Member State |
14 Nov 2025
08:00 CET |
CMB.TECH |
PERSBERICHT: CMB.TECH kondigt Q3 2025 resultaten aan op 26/11/2025
|
50206030 Marine Transportation |
Other subject |
14 Nov 2025
07:38 CET |
HYLORIS |
Hyloris Announces Positive Clinical Study Results for IV Aspirin
|
20103010 Biotechnology |
Corporate life |
14 Nov 2025
01:30 CET |
NYXOAH SA |
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
22:35 CET |
NYXOAH SA |
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
22:12 CET |
NYXOAH SA |
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
22:12 CET |
NYXOAH SA |
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
17:55 CET |
NEXTENSA |
NEXTENSA ACHIEVES SOLID RESULTS IN Q3
|
35101010 Real Estate Holding and Development |
Commercial results |
13 Nov 2025
17:55 CET |
NEXTENSA |
NEXTENSA ZET SOLIDE RESULTATEN NEER IN Q3
|
35101010 Real Estate Holding and Development |
Commercial results |
13 Nov 2025
17:55 CET |
NEXTENSA |
NEXTENSA RÉALISE DES RÉSULTATS SOLIDES EN Q3
|
35101010 Real Estate Holding and Development |
Commercial results |
13 Nov 2025
07:45 CET |
AGFA-GEVAERT |
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
07:45 CET |
AGFA-GEVAERT |
De Agfa-Gevaert Groep in het derde kwartaal van 2025: voortdurende achteruitgang in medische film, sterke groei cloud en SaaS in HealthCare IT, zwakkere markten in Digital Print & Chemicals
|
20102010 Medical Equipment |
Other subject |
13 Nov 2025
07:05 CET |
KBC |
KBC Groep: KBC rondt een eerste succesvolle significante risico-overdrachtstransactie af op een bedrijfskredietportefeuille van 4,2 miljard euro
|
30101010 Banks |
Other subject |
13 Nov 2025
07:05 CET |
KBC |
KBC Group: KBC successfully completes its inaugural significant risk transfer transaction on a 4.2 billion euros corporate loan portfolio
|
30101010 Banks |
Other subject |
13 Nov 2025
07:05 CET |
KBC |
KBC Groupe: KBC effectue avec succès sa première transaction de transfert de risque significatif sur un portefeuille de prêts aux entreprises de 4,2 milliards d'euros
|
30101010 Banks |
Other subject |